BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 15855703)

  • 1. [Role of the bone mineral density investigation through measuring of peripheral dual-energetic x-ray absorption in prevention of fractures in children with osteogenesis imperfecta].
    Saganelidze KhZ
    Georgian Med News; 2005 Mar; (120):61-4. PubMed ID: 15855703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate treatment in osteogenesis imperfecta.
    Madenci E; Yilmaz K; Yilmaz M; Coskun Y
    J Clin Rheumatol; 2006 Apr; 12(2):53-6. PubMed ID: 16601536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density correlation with fractures in nonambulatory pediatric patients.
    Khoury DJ; Szalay EA
    J Pediatr Orthop; 2007; 27(5):562-6. PubMed ID: 17585268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dual energy x-ray absorptiometry in aiding the diagnosis of pediatric osteogenesis imperfecta.
    Moore MS; Minch CM; Kruse RW; Harcke HT; Jacobson L; Taylor A
    Am J Orthop (Belle Mead NJ); 1998 Dec; 27(12):797-801. PubMed ID: 9880097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional significance of bone density measurements in children with osteogenesis imperfecta.
    Huang RP; Ambrose CG; Sullivan E; Haynes RJ
    J Bone Joint Surg Am; 2006 Jun; 88(6):1324-30. PubMed ID: 16757767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate treatment in children with osteogenesis imperfecta.
    Akcay T; Turan S; Guran T; Bereket A
    Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.
    Szulc P; Munoz F; Duboeuf F; Marchand F; Delmas PD
    Bone; 2006 Apr; 38(4):595-602. PubMed ID: 16249130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone mineral content in osteogenesis imperfecta].
    Rajtár M; László A; Beviz J; Bossányi A; Almási L; Csernay L
    Orv Hetil; 1996 Jul; 137(28):1519-23. PubMed ID: 8757074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children.
    Ward KA; Roberts SA; Adams JE; Mughal MZ
    Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.
    Löwing K; Aström E; Oscarsson KA; Söderhäll S; Eliasson AC
    Acta Paediatr; 2007 Aug; 96(8):1180-3. PubMed ID: 17578486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and fracture threshold in South Indian elderly.
    Usha G; Krishnaswamy B
    J Assoc Physicians India; 2002 Feb; 50():247-9. PubMed ID: 12038657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between bone mineral density and hearing loss in osteogenesis imperfecta.
    Swinnen FK; De Leenheer EM; Goemaere S; Cremers CW; Coucke PJ; Dhooge IJ
    Laryngoscope; 2012 Feb; 122(2):401-8. PubMed ID: 22252604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic and secondary osteoporosis in childhood].
    Rossi F; Perrotta S; Falcone E; Gimigliano F; Iodice M; Vetrella S; Iolascon G
    Minerva Pediatr; 2005 Oct; 57(5):203-11. PubMed ID: 16205605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in children with mild osteogenesis imperfecta.
    Zionts LE; Nash JP; Rude R; Ross T; Stott NS
    J Bone Joint Surg Br; 1995 Jan; 77(1):143-7. PubMed ID: 7822373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.